Pallidotomy and bradykinesia: Implications for basal ganglia function

Neurology

Volumn 51, Issue 3, 1998, Pages 796-803

  Pfann, Kerstin D ^a   Penn, Richard D ^b   Shannon, Kathleen M ^b   Corcos, Daniel M ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; BRADYKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; ELBOW FLEXION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOTOR PERFORMANCE; PALLIDOTOMY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0031751090     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.3.796     Document Type: Article

References (50)

1. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13(7):281-285.
2. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.
3. Garcia-Rill E. The basal ganglia and the locomotor regions. Brain Res Rev 1986;11:47-63.
4. Miller WC, DeLong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter M, Jayaraman A, eds. Basal ganglia II. New York: Plenum Press, 1987:415-427.
5. Filion M, Tremblay L, Bedard PJ. Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys. Brain Res 1988;444:165-176.
6. Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:142-151.
7. Wichmann T, DeLong MR. Pathophysiology of parkinsonian motor abnormalities. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y, eds. Advances in neurology. New York: Raven Press, 1993:53-61.
8. Lozano AM, Lang AE, Glavez-Jiminez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
9. Dogali M, Fazzini E, Kolodny E, et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-761.
10. Baron MS, Vitek JL, Bakay RAE, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40:355-366.
11. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997;337:1036-1042.
12. Fazzini E, Dogali M, Sterio D, Eidelberg D, Beric A. Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy. Neurology 1997;48:1273-1277.
13. Kopyov O, Jacques D, Duma C, et al. Microelectrode-guided posteroventral medial radiofrequency pallidotomy for Parkinson's disease. J Neurosurg 1997;87:52-59.
14. Shannon KM, Penn RD, Kroin JS, et al. Stereotactic pallidotomy for the treatment of Parkinson's disease: efficacy and adverse effects at 6 months in 26 patients. Neurology 1998;50: 434-438.
15. Sutton JP, Couldwell W, Lew MF, et al. Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. Neurosurgery 1995;36:1112-1116.
16. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
17. Iacono RP, Shima F, Lonser RR, Kuniyoshi S, Maeda G, Yamada S. The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery 1995;36:1118-1125.
18. Svennilson E, Torvik A, Lowe R, Leskell L. Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. Acta Psychiatr Neurol Scand 1960;35:358-377.
19. Cooper IS. Surgical treatment of parkinsonism. Annu Rev Med 1965;16:309-330.
20. Iacono RP, Lonser RR. Reversal of Parkinson's akinesia by pallidotomy. Lancet 1994;343:418-419.
21. Laitinen LV. Ventroposterolateral pallidotomy. Stereotact Funct Neurosurg 1994;62:41-52.
22. Laitinen LV, Bergenheim AT, Hariz MI. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotact Funct Neurosurg 1992;58:14-21.
23. Hallett M, Shahani BT, Young RR. Analysis of stereotyped voluntary movements at the elbow in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1977;40:1129-1135.
24. Hallett M, Khoshbin S. A physiological mechanism of bradykinesia. Brain 1980;103:301-314.
25. Corcos DM, Pfann KD, Buchman AS. Defective preprogramming does not account for the clinical deficits of Parkinson's disease. Behav Brain Sci 1996;19(1):73-74.
26. Shannon KM, Penn RD, Kroin JS, et al. Stereotactic pallidotomy for the treatment of Parkinson's disease: efficacy and adverse effects at 6 months in 26 patients. Neurology 1997; 48(suppl 2):A137.
27. Fahn S, Elton RL, the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease. Vol. 2. Florham Park, NJ: MacMillan Healthcare Information, 1987:153-163.
28. Langston JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantation (CAPIT). Mov Disord 1992;7:2-13.
29. Ceballos-Baumann AO, Obeso JA, Vitek JL, et al. Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet 1994;344:814.
30. Filion M, Tremblay L, Bedard PJ. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991; 547:152-161.
31. Chevalier G, Deniau JM. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci 1990; 13(7):277-280.
32. Mink JW, Thach WT. Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes. J Neurophysiol 1991;65:273-300.
33. Mink JW, Thach WT. Basal ganglia motor control. II. Late pallidal timing relative to movement onset and inconsistent pallidal coding of movement parameters. J Neurophysiol 1991;65:301-329.
34. Mink JW, Thach WT. Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. J Neurophysiol 1991;65:330-351.
35. Tremblay L, Filion M. Responses of pallidal neurons to striatal stimulation in intact waking monkeys. Brain Res 1989; 498:1-16.
36. Tremblay L, Filion M, Bedard PJ. Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism. Brain Res 1989;498:17-33.
37. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996;6:751-758.
38. Draper IT, Johns RJ. The disordered movement in parkinsonism and the effect of drug treatment. Bull Johns Hopkins Hosp 1964;115:465-480.
39. Flowers KA. Visual "closed loop" and "open loop" characteristics of voluntary movement in patients with parkinsonism and intention tremor. Brain 1976;99:269-310.
40. Berardelli A, Dick JPR, Rothwell JC, Day BL, Marsden CD. Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1986;49:1273-1279.
41. Percheron G, Filion M. Parallel processing in the basal ganglia: up to a point. Trends Neurosci 1991;14(2):55-56.
42. Horak FB, Anderson ME. Influence of globus pallidus on arm movements in monkeys. I. Effects of kainic acid-induced lesions. J Neurophysiol 1984;52:290-304.
43. Hore J, Vilis T. Arm movement performance during reversible basal ganglia lesions in the monkey. Exp Brain Res 1980;39: 217-228.
44. Inase M, Buford JA, Anderson ME. Changes in the control of arm position, movement, and thalamic discharge during local inactivation in the globus pallidus of the monkey. J Neurophysiol 1996;75:1087-1104.
45. Alamy M, Pons J-C, Gambarelli D, Trouche E. A defective control of small-amplitude movements in monkeys with globus pallidus lesions: an experimental study on one component of pallidal bradykinesia. Behav Brain Res 1996;72:57-62.
46. Kato M, Kimura M. Effects of reversible blockade of basal ganglia on a voluntary arm movement. J Neurophysiol 1992; 68:1516-1534.
47. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994;117:877-897.
48. Crossman AR. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment. Mov Disord 1990;5:100-108.
49. Blanchet PJ, Gomez-Mancilla B, Di Paolo T, Bedard PJ. Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia? Fundam Clin Pharmacol 1995; 9:434-442.
50. Brown RG, Limousin P, Jahanshahi M, Quinn N, Obeso J, Rothwell JC. Posteroventral pallidotomy (PVP) in Parkinson's disease (PD). I: effects on initiation and execution of simple and complex movement. Mov Disord 1997;12(suppl 1): 129(P487).